Similar articles

• A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome.

  Stein DP, Dambrosia JM, Dalakas MC. Stein DP, et al. Ann N Y Acad Sci. 1995 May 25;753:296-302. doi: 10.1111/j.1749-6632.1995.tb27555.x. Ann N Y Acad Sci. 1995. PMID: 7611638 Clinical Trial.
• Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial.

  Vasconcelos OM, Prokhorenko OA, Salajegheh MK, Kelley KF, Livornese K, Olsen CH, Vo AH, Dalakas MC, Halstead LS, Jabbari B, Campbell WW. Vasconcelos OM, et al. Neurology. 2007 May 15;68(20):1680-6. doi: 10.1212/01.wnl.0000261912.53959.b4. Neurology. 2007. PMID: 17502549 Clinical Trial.
• [Post-polio syndrome].

  Benhaberou-Brun D. Benhaberou-Brun D. Perspect Infirm. 2014 Sep-Oct;11(4):38-40. Perspect Infirm. 2014. PMID: 25269239 French. No abstract available.
• Amantadine and fatigue of multiple sclerosis.

  Kemp BA, Gora ML. Kemp BA, et al. Ann Pharmacother. 1993 Jul-Aug;27(7-8):893-5. Ann Pharmacother. 1993. PMID: 8364274 Review. No abstract available.
• [Fatigue syndrome in chronic neurological disorders].

  Brola W, Ziomek M, Czernicki J. Brola W, et al. Neurol Neurochir Pol. 2007 Jul-Aug;41(4):340-9. Neurol Neurochir Pol. 2007. PMID: 17874343 Review. Polish.